首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Successful Fertility Restoration after Allogenic Hematopoietic Stem Cell Transplantation
Institution:1. National Cancer Institute, Medical Oncology Branch, Bethesda, Maryland;2. Department of Endocrinology, St. George’s Hospital, Blackshaw Road, London, United Kingdom,;3. National Heart, Lung, and Blood Institute, Molecular and Clinical Hematology Branch, Bethesda, Maryland;4. Columbia Fertility Associates, Washington, DC.;1. Department of Endocrinology and Metabolism, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;2. Department of Pathology, The Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan;3. Department of Nephro-urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.;1. Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine;2. Department of Endocrinology, Metabolism, and Infectious Diseases, Hirosaki University School of Medicine & Hospital;3. Clinical Research Institute, National Hospital Organization, Kyoto Medical Center;4. Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine
Abstract:ObjectiveMyeloablative conditioning regimens given prior to hematopoietic stem cell transplantation (HSCT) frequently cause permanent sterility in men. In patients with sickle cell disease (SCD) we use a nonmyeloablative regimen with sirolimus, alemtuzumab, and low-dose total-body irradiation (300 centigrays) with gonadal shielding preceding allogeneic HSCT. We report here the restoration of azoospermia in a patient with SCD after allogeneic HSCT. We discuss the impact of our patient’s underlying chronic medical conditions and the therapies he had received (frequent blood transfusions, iron chelating drugs, ribavirin, hydroxyurea, opioids), as well as the impact of the nonmyeloablative conditioning regimen on male gonadal function, and we review the literature on this topic.MethodsWe determined the patient’s reproductive hormonal values and his semen parameters before, during, and after HSCT and infertility treatment. In addition, we routinely measured his serum laboratory parameters pertinent to SCD and infertility, such as iron and ferritin levels. A karyotype analysis was performed to assess the potential presence of Klinefelter syndrome. Finally, imaging studies of the patient’s brain and testes were done to rule out further underlying pathology.ResultsA 42-year-old man with SCD, transfusional iron overload, and hepatitis C underwent a nonmyeloablative allogeneic HSCT. One year later he desired to father a child but was found to be azoospermic in the context of hypogonadotropic hypogonadism. Restoration of fertility was attempted with human chorionic gonadotropin (2,000 IU) plus human menopausal gonadotropin (75 IU follicle-stimulating hormone) injected subcutaneously 3 times weekly. Within 6 months of treatment, the patient’s serum calculated free testosterone value normalized, and his sperm count and sperm motility improved. After 10 months, he successfully initiated a pregnancy through intercourse. The pregnancy was uncomplicated, and a healthy daughter was delivered naturally at term.ConclusionDespite exposure to several gonadotoxins, transfusional iron overload and nonmyeloablative conditioning with radiation causing severe testicular atrophy suggesting extensive damage to seminiferous tubules and possibly Leydig cells, gonadotropins were efficacious in restoring our patient’s reproductive capability. (Endocr Pract. 2014;20:e157-e161)
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号